Compare EVH & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVH | BTG |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Precious Metals |
| Sector | Consumer Discretionary | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 667.0M | 7.1B |
| IPO Year | 2015 | 2007 |
| Metric | EVH | BTG |
|---|---|---|
| Price | $3.53 | $5.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $7.93 | $6.00 |
| AVG Volume (30 Days) | 1.8M | ★ 23.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,957,000.00 | N/A |
| Revenue This Year | $33.89 | $38.08 |
| Revenue Next Year | $15.84 | $28.46 |
| P/E Ratio | ★ N/A | $34.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $3.57 |
| 52 Week High | $9.11 | $6.29 |
| Indicator | EVH | BTG |
|---|---|---|
| Relative Strength Index (RSI) | 34.23 | 50.63 |
| Support Level | $3.61 | $5.08 |
| Resistance Level | $3.68 | $5.78 |
| Average True Range (ATR) | 0.18 | 0.18 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 7.84 | 37.10 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.